Knoll Pharmaceuticals

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Knoll Pharmaceuticals was a drug development company founded by Albert Knoll and Hans Knoll in Germany in 1886. The company was taken over by German BASF in 1975, which sold it to Abbott Laboratories on 30 June 2002 for $6.9 bln.[1][2]

It was the developer of several drugs:

Sibutramine, a serotonin-norepinephrine reuptake inhibitor prescribed as an adjunct in the treatment of exogenous obesity, maketed by Abbott but withdrawn from the market in the United States and most other countries in 2010 [3]

Propafenone, an antiarrhythmic agent, marketed by Abbott.

Isophan, a slightly modified version of the methamphetamine drug Pervitin, which the nazi government in 1940 distributed to the German army and air force in an effort to win WW2.[4]

Ancrod (also known as Viprinex), a defibrinogenating agent derived from the venom of Malayan pit vipers, under development for the treatment of acute ischemic stroke.[5]

External links[edit]


  1. ^ Cuba, Valerie (3 April 2001). "Knoll Pharmaceuticals/ BASF Pharma". Powerpoint presentation. Roanoke College. Retrieved 9 December 2012. 
  2. ^ "Pharma business sold for $6.9 billion". Press release. BASF Corporation. 15 December 2000. Retrieved 9 December 2012. 
  3. ^ Rockoff, Jonathan D.; Dooren, Jennifer Corbett (October 8, 2010). "Abbott Pulls Diet Drug Meridia Off US Shelves". The Wall Street Journal. Retrieved 8 October 2010. 
  4. ^ "The Nazi Death Machine: Hitler's Drugged Soldiers". Der Spiegel, May 06, 2005. 
  5. ^ [1]